RAC 2.20% $1.78 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-32

  1. 1,248 Posts.
    lightbulb Created with Sketch. 2462

    FTO expression was originally in as a secondary end point but was later removed.

    We could have been presenting something even more exciting at this years ASH.

    We’re not under the radar though..
    https://hotcopper.com.au/data/attachments/5714/5714624-74e6512299b2546c010b9f3ac6514508.jpg


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.